The role of caspases in methotrexate-induced gastrointestinal toxicity

H T Papaconstantinou1, C Xie, W Zhang

  • 1Department of Surgery, University of Texas Medical Branch, Galveston, TX 77555-0542, USA.

Surgery
|October 31, 2001
PubMed
Abstract

Insights

Methotrexate chemotherapy causes gut apoptosis by activating specific caspases (cell-death proteins) in intestinal cells. Inhibiting these caspases may reduce chemotherapy-induced enterocolitis.

Area of Science:

  • Cell biology
  • Molecular mechanisms of apoptosis
  • Gastrointestinal oncology

Background:

  • Methotrexate chemotherapy is limited by enterocolitis, a major toxicity.
  • Methotrexate induces gut mucosal apoptosis, but the molecular mechanisms are unclear.
  • Caspases are key proteases involved in apoptosis, activated in a stimulus-specific manner.

Purpose of the Study:

  • Establish an in vitro model for methotrexate-induced gut apoptosis.
  • Determine the role of caspases in this process within intestinal epithelial cells.

Main Methods:

  • Rat intestinal epithelial cells (RIE-1) were treated with methotrexate.
  • Apoptosis was assessed via DNA fragmentation and nuclear staining.
  • Caspase activation was measured using fluorogenic substrates.
  • A general caspase inhibitor (ZVAD-fluoromethyl ketone) was used to assess caspase involvement.

Main Results:

  • Methotrexate induced apoptosis and reduced cell number in RIE-1 cells.
  • Sequential activation of caspases 9, 2, and 3 was observed.
  • Caspases 1 and 8 remained inactive.
  • ZVAD-fluoromethyl ketone significantly inhibited methotrexate-induced apoptosis and caspase activation.

Conclusions:

  • Methotrexate activates specific caspases, leading to apoptosis in intestinal epithelial cells.
  • Caspases play a crucial role in methotrexate-induced apoptosis.
  • Targeting caspases could be a therapeutic strategy to mitigate methotrexate-induced enterocolitis.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...